Design of homogeneous, monopegylated erythropoietin analogs with preserved in vitro bioactivity
- 30 June 2006
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 34 (6) , 697-704
- https://doi.org/10.1016/j.exphem.2006.02.011
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Population pharmacokinetic analysis of pegylated human erythropoietin in ratsJournal of Pharmaceutical Sciences, 2004
- Derivatives of Erythropoietin That Are Tissue Protective But Not ErythropoieticScience, 2004
- Comparing N-glycan processing in mammalian cell lines to native and engineered lepidopteran insect cell linesGlycoconjugate Journal, 2004
- Design and Chemical Synthesis of a Homogeneous Polymer-Modified Erythropoiesis ProteinScience, 2003
- Rational Design of a Potent, Long-Lasting Form of Interferon: A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis CBioconjugate Chemistry, 2001
- NMR structure of human erythropoietin and a comparison with its receptor bound conformationNature Structural & Molecular Biology, 1998
- A sequential dimerization mechanism for erythropoietin receptor activation.Proceedings of the National Academy of Sciences, 1996
- Epoetin AlfaDrugs, 1995
- Influence of codon usage and translation initiation codon context in theAcNPV-based expression system: Computer analysis using homologous and heterologous genesVirus Genes, 1995
- Structural and functional characterisation of recombinant human erythropoietin analoguesFEBS Letters, 1993